Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
MEIBUM
1 other identifier
observational
185
2 countries
2
Brief Summary
The purpose of this study is to determine the incidence and characteristics of eyelid inflammatory disorders during general ophthalmological consultations and to demonstrate association between palpebral pathologies and ocular surface pathologies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2012
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 6, 2012
CompletedFirst Posted
Study publicly available on registry
March 13, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedSeptember 1, 2015
August 1, 2015
2.1 years
March 6, 2012
August 31, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of eyelid disorders in general ophthalmological practice
* Systematic description of the eyelid, the ocular surface and the dermatological aspect of the face * Occurrence of Meibomian Gland Dysfunction(MGD).
Day 1
Secondary Outcomes (3)
Association between palpebral pathologies and ocular surface pathologies
Day 1
Impact of eyelid disorder on patient's daily life
Day 1
Current recommended strategy to treat eyelids disorders
Day 1
Study Arms (1)
Outpatients attending general ophthalmologic consultation
* Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation * Patients informed of the objectives of the survey and agreeing to participate. * Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
Eligibility Criteria
Patients will be eligible for inclusion if all these criteria are respected: * Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation * Patients informed of the objectives of the survey and agreeing to participate. * Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
You may qualify if:
- Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation
- Patients informed of the objectives of the survey and agreeing to participate.
- Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laboratoires Thealead
- Iris Pharmacollaborator
- Axial Biotech, Inccollaborator
Study Sites (2)
Consultation office
Heidelberg, 69121, Germany
USIO Departamento de Oftalmologia Hospital Clínico San Carlos
Madrid, 28040, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
José Manuel Benitez del Castillo, Professor
USIO, Departamento de Oftalmología, Hospital Clínico San Carlos, 28040 Madrid, Spain
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2012
First Posted
March 13, 2012
Study Start
March 1, 2012
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
September 1, 2015
Record last verified: 2015-08